Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation

Area of Science:

• Nephrology
• Transplantation Surgery
• Pharmacology

Background:

• Renal ischemia-reperfusion injury (IRI) occurs during surgeries like renal transplantation and aortic procedures.
• Previous research indicated pre-ischemic adenosine protects kidneys via A(1) adenosine receptor (AR) activation.
• In other organs, post-ischemic adenosine protects against reperfusion injury via A(2a) ARs.

Purpose of the Study:

• To investigate if adenosine administration after renal ischemia protects kidney function in rats.
• To identify the specific adenosine receptor subtype and intracellular signaling pathways involved in this protection.

Main Methods:

• Rats underwent 45 minutes of renal ischemia followed by reperfusion.
• Treatments included systemic adenosine, selective AR agonists/antagonists, and dibutyryl cyclic adenosine monophosphate (cAMP).
• Renal function was assessed by creatinine levels and kidney histology.

Main Results:

• Post-ischemic adenosine treatment significantly improved renal function and reduced tubular damage.
• Protection was mediated by A(2a) AR activation, as evidenced by agonist (CGS-21680) mimicking and antagonist (CSC) blocking the protective effects.
• A(1) and A(3) ARs were not involved; cyclic adenosine monophosphate (cAMP) was identified as a key downstream signaling intermediate.

Conclusions:

• Post-ischemic administration of adenosine protects rat kidneys from reperfusion injury through A(2a) AR activation and cAMP signaling.
• These findings highlight the therapeutic potential of A(2a) adenosine receptor agonists for managing renal ischemia.